Payout ratio of Supernus Pharmaceuticals, Inc.
The payout ratio is calculated by dividing the dividends paid out by the net earnings for a certain period. It is usually expressed as a percentage. The part of the earnings not paid to investors is left for investment to provide for future earnings growth. Investors seeking high current income and limited capital growth prefer companies with high payout ratio. However investors seeking capital growth may prefer lower payout ratio because capital gains are taxed at a lower rate. High growth firms in early life generally have low or zero payout ratios. As they mature, they tend to return more of the earnings back to investors.
Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. It offers Oxtellar XR, an extended-release oxcarbazepine for use in the treatment of epilepsy; and Trokendi XR, an extended-release topiramate, which is used for the treatment of epilepsy. The company's product candidates comprise SPN-810, a molindone hydrochloride that is in Phase III clinical trial for the treatment of impulsive aggression in patients with attention deficit hyperactivity disorder (ADHD); and SPN-812, a viloxazine hydrochloride, which has completed Phase IIb trial that is used for the treatment of ADHD. It also develops SPN-809, a viloxazine hydrochloride, which is in Phase II ready clinical trial for the treatment of depression. The company markets its products through wholesalers and pharmaceutical distributors. Supernus Pharmaceuticals, Inc. was founded in 2005 and is based in Rockville, Maryland.
|CHKE Cherokee Inc.||NASDAQ > Consumer Non-Durables > Apparel||4.89|
|CAR Avis Budget Group, Inc.||NASDAQ > Consumer Services > Rental/Leasing Companies||4.89|
|PBPB Potbelly Corporation||NASDAQ > Consumer Services > Restaurants||4.89|
|INFN Infinera Corporation||NASDAQ > Public Utilities > Telecommunications Equipment||4.90|
|KRYS Krystal Biotech, Inc.||NASDAQ > Health Care > Biotechnology: Biological Products (No Diagnostic Substances)||4.90|
|WMS Advanced Drainage Systems, Inc.||NYSE > Capital Goods > Containers/Packaging||4.91|
|SUPN Supernus Pharmaceuticals, Inc.||NASDAQ > Health Care > Major Pharmaceuticals||4.91|
|PCO Pendrell Corporation||NASDAQ > Miscellaneous > Multi-Sector Companies||879.05|
|WTM White Mountains Insurance Group, Ltd.||NYSE > Finance > Property-Casualty Insurers||938.42|
|DCIX Diana Containerships Inc.||NASDAQ > Transportation > Marine Transportation||1,903.21|
|SEB Seaboard Corporation||NYSEMKT > Finance > Investment Bankers/Brokers/Service||2,890.09|
|BRK-A Berkshire Hathaway Inc.||NYSE > Finance > Property & Casualty Insurance||187,384.70|
|BRK-B Berkshire Hathaway Inc.||NYSE > Finance > Property & Casualty Insurance||187,384.70|